Secondary prevention of stroke in elderly people in Poland—Results of PolSenior study

Sienkiewicz-Jarosz, 2011, Incidence and case fatality rates of first-ever stroke—comparison of data from two prospective population-based studies conducted in Warsaw, Neurol Neurochir Pol, 45, 207, 10.1016/S0028-3843(14)60073-6 Mazurek, 2005, Umieralność z powodu udarów mózgu w Polsce – rola badań obserwacyjnych opartych na danych z baz informatycznych, Wiad Lek, 58, 397 Kral, 2010, Oral antiplatelet therapy in stroke prevention. Minireview, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 154, 203, 10.5507/bp.2010.031 Kwolek, 2009, 33 Kesteloot, 2006, Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000, Eur Heart J, 27, 107, 10.1093/eurheartj/ehi511 Varon, 2009, Antiplatelet agents, Hematology, 1, 267, 10.1182/asheducation-2009.1.267 Antithrombotic Trialists’ Collaboration, 2002, Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 Shulga, 2011, Antiplatelets in secondary stroke prevention, Front Neurol, 2, 1, 10.3389/fneur.2011.00036 Hirsh, 2001, Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range, Chest, 119, 8, 10.1378/chest.119.1_suppl.8S Bledowski, 2011, Medical, psychological and socioeconomic aspects of aging in Poland. Assumptions and objectives of the PolSenior project, Exp Gerontol, 46, 1003, 10.1016/j.exger.2011.09.006 2012 Asberg, 2010, Ischemic stroke and secondary prevention in clinical practice, Stroke, 41, 1338, 10.1161/STROKEAHA.110.580209 Glader, 2010, Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke, Stroke, 41, 397, 10.1161/STROKEAHA.109.566950 Gao, 2010, Risk assessment and aspirin use in Asian and Western populations, Vasc Health Risk Manag, 6, 943 Verro, 2008, Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA, Stroke, 39, 1358, 10.1161/STROKEAHA.107.496281 Halkes, 2006, Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial, Lancet, 367, 1665, 10.1016/S0140-6736(06)68734-5 Łabuz-Roszak, 2012, Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland, BMC Cardiovasc Disord, 12, 98, 10.1186/1471-2261-12-98